EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...

The European stock markets have broadly underperformed their global peers, particularly Wall Street throughout the year. Several factors have contributed to this trend, including a lack of robust ...

In a report published on its website on Dec. 2, the Commission on Audit (COA) said the BSP shelled ... based on the June 5, 2023, BSP reference rate of 1 euro to P59.934. De La Rue was responsible ...